Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27 USD | +22.84% | +14.60% | -38.62% |
May. 03 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
May. 03 | ModivCare Shares Jump After Higher Q1 Net Service Revenue | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The stock, which is currently worth 2024 to 0.51 times its sales, is clearly overvalued in comparison with peers.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- The company is in debt and has limited leeway for investment
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-38.62% | 383M | C- | ||
+13.70% | 81.4B | C+ | ||
-29.20% | 70.18B | B- | ||
+9.72% | 29.08B | C+ | ||
-11.43% | 16.97B | B | ||
-0.43% | 16.96B | A- | ||
-0.31% | 15.26B | A- | ||
+3.42% | 12.41B | A- | ||
+28.34% | 11.79B | B- | ||
-30.70% | 11.95B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MODV Stock
- Ratings ModivCare Inc.